"If you eat this and do not see sunlight for 100 days, you will become human."
According to Korean mythology, those were the exact conditions the divine king Hwanung set for a bear as he handed over bundles of sacred mugwort and garlic.
Koreans have been consuming garlic for thousands of years. With an annual per-capita consumption of around six kilograms—translating to roughly three or four cloves a day—South Korea ranks among the highest garlic-consuming nations in the world. But while garlic has long been celebrated culturally for boosting baseline vitality, a recent animal study reveals that specific compounds within it can significantly strengthen skeletal muscle. Strikingly, researchers found that this muscle-protecting pathway does not work the way anyone expected; its origin point begins far away from the muscle itself, embedded deep within body fat.
From Adipose Tissue to Axons: How the Pathway Rewrites Muscle Science
When middle-aged individuals worry about sarcopenia (age-related muscle loss), the standard medical prescription is straightforward: eat more protein and exercise. The focus remains squarely on direct, localized muscle stimulation.
However, a newly mapped biological pathway flips this convention on its head. A joint research team from the Institute for Research on Productive Aging (IRPA) in Tokyo and Wakunaga Pharmaceutical isolated a specific bioactive metabolite called S-1-propenyl-L-cysteine (S1PC) from aged garlic extract (AGE)—an extract produced by soaking raw garlic in an alcohol solution and aging it for at least 10 months.
S1PC does not target muscle tissue directly. Instead, it acts first on adipose (fat) tissue, where it activates an enzyme known as liver kinase B1 (LKB1). Far from being a simple, passive warehouse for storing excess calories, fat tissue functions as an active secretory organ. When S1PC activates LKB1, it triggers a cascade that prompts fat cells to secrete an anti-aging protein called extracellular nicotinamide phosphoribosyltransferase (eNAMPT) into the bloodstream.
This protein travels through the circulatory system directly to the brain's hypothalamus. From there, it transmits regulatory signals down the autonomic nervous system, which ultimately prompts skeletal muscles to respond. This unique fat-brain-muscle route runs entirely counter to the conventional view that muscle architecture can only be modified through direct, localized stimulation.
To test this mechanism, the research team administered S1PC daily for eight months to 15-month-old mice. The treated mice demonstrated a significant increase in skeletal muscle contractile force, broad improvements across 31 individual indicators of physical frailty, and a complete recovery of disrupted core temperature-regulation mechanisms.
The researchers followed this with a human clinical study involving 44 healthy Japanese men and women between the ages of 20 and 49. After receiving a single 25 mg dose of S1PC, participants aged 40 and older with normal body fat exhibited a notable rise in circulating blood eNAMPT levels two hours later. Interestingly, this response was more pronounced in individuals with higher baselines of body fat, suggesting that the pathway operates more efficiently when a certain threshold of adipose tissue is present. However, the human study has clear limitations: while the animal trials confirmed physical improvements in muscle strength and frailty, the human trial only verified the initial spike in circulating eNAMPT levels.
Raw vs. Aged: Why Culinary Garlic Isn't Enough
Because garlic is already a dominant culinary staple, it is easy to assume these therapeutic benefits can be achieved through regular meals. However, the critical factor is the aging process itself. S1PC exists in raw garlic only in trace amounts. It is only when allicin—the volatile compound responsible for garlic's pungent odor—gradually breaks down during prolonged aging that S1PC concentrations rise sharply. Consequently, consuming massive quantities of raw garlic will not replicate these metabolic effects. Conveniently, as allicin breaks down during aging, aged garlic extract retains virtually no odor.
While aged garlic extract supplements are commercially available on the market, actual S1PC levels can vary dramatically depending on the manufacturer's specific processing methods. Similarly, while black garlic generates some S1PC during its fermentation and aging cycles, its exact chemical content remains highly inconsistent across different production methods.
The peer-reviewed findings were published in the May 2026 issue of the international biomedical journal Cell Metabolism. As with all emerging research, institutional context is important to note: the study was funded directly by Wakunaga Pharmaceutical—a company that commercializes garlic-extract products—and the research team has jointly filed a U.S. patent for the compound. Further long-term human clinical trials are necessary to determine whether these systemic muscle benefits hold true over years of extended use.
Nevertheless, the study successfully redefines our understanding of fat tissue, moving it away from the stigma of passive weight gain and reframing it as a critical signaling organ that actively orchestrates systemic longevity and muscle function.
